Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare

Cadila Healthcare

BSE: 532321|NSE: CADILAHC|ISIN: INE010B01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 19, 09:22
243.00
1.65 (0.68%)
VOLUME 2,540
LIVE
NSE
Nov 19, 09:26
243.00
1.5 (0.62%)
VOLUME 67,200
News on Cadila Healthcare
Select Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Cadila Healthcare share price rises 4% after USFDA nod for arthritis drug

1.50 pm | 18 Nov 2019 |  Source: Moneycontrol.com

Zydus Cadila announced the second Phase III DREAM-D trials of Desidustat, an Investigational New Drug (IND) targeted at treating anemia in dialysis de...

Stocks in the news: RComm, Tata Steel, Asian Oilfield, HIL, HCL Info, BPCL, Wockhardt, Unichem Lab

7.54 am | 18 Nov 2019 |  Source: Moneycontrol.com

Reliance Communications | Wockhardt | BPCL | HCL Infosystems | Asian Oilfield Services and Tata Steel are stocks, which are in news today....

Hold Cadila Healthcare; target of Rs 260: ICICI Direct

2.17 pm | 15 Nov 2019 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 260 in its research report dated November 14, 2019....

Brokerages remain bullish, Cadila Healthcare share price up 3%

10.38 am | 14 Nov 2019 |  Source: Moneycontrol.com

Macquarie also retained its outperform rating on the stock as it would buy the stock if it falls, but slashed its target price to Rs 270 (from Rs 292 ...

Stocks in the news: Tata Motors, BHEL, Adani Ports, Britannia, Lupin, Godrej Industries, Tata Power, Balmer Lawrie

7.52 am | 13 Nov 2019 |  Source: Moneycontrol.com

Indian Hotels | Cadila Healthcare | NHPC | ABB India | IRCTC | Balmer Lawrie| Bombay Dyeing and Hindalco Industries are stocks, which are in news toda...

Zydus Cadila gets USFDA nod for generic muscle relaxing injection

12.08 pm | 05 Nov 2019 |  Source: PTI

The injection will be manufactured at Liva Pharmaceuticals, a wholly-owned subsidiary of Cadila...

Zydus Cadila receives warning letter from USFDA for formulation plant

8.37 pm | 04 Nov 2019 |  Source: PTI

The company said it has already taken multiple steps after the inspection of the facility by the US Food and Drug Administration (USFDA) and would con...

Cadila Healthcare rises nearly 5% on EIR from USFDA

12.28 pm | 31 Oct 2019 |  Source: Moneycontrol.com

The share price declined 25 percent in the last 1 year....

Initiate long positions in auto, banks, metal stocks; IndusInd Bank ripe for bounce back

10.50 am | 17 Oct 2019 |  Source: Moneycontrol.com

Among sectors we prefer to initiate longs in Auto, Banking and Metal space for reasonable upside as the risk reward remains favourable....

Cadila Healthcare Q2 PAT may dip 23% YoY to Rs. 321.5 cr: Emkay

3.49 pm | 14 Oct 2019 |  Source: Moneycontrol.com

Net Sales are expected to increase by 17.4 percent Y-o-Y (down 0.6 percent Q-o-Q) to Rs. 3,475.2 crore, according to Emkay....

Cadila Healthcare gains 4% on USFDA approval for cholesterol-lowering drug

2.00 pm | 09 Oct 2019 |  Source: Moneycontrol.com

The drug will be manufactured at the group’s formulations-manufacturing facility at Ahmedabad's SEZ....

Hold Cadila Healthcare; target of Rs 275: Sharekhan

3.23 pm | 14 Aug 2019 |  Source: Moneycontrol.com

Sharekhan recommended Hold rating on Cadila Healthcare with a target price of Rs 275 in its research report dated August 09, 2019....

Buy Cadila Healthcare; target of Rs 265: HDFC Securities

1.31 pm | 14 Aug 2019 |  Source: Moneycontrol.com

HDFC Securities is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 265 in its research report dated Aug...

Hold Cadila Healthcare; target of Rs 250: ICICI Direct

3.17 pm | 13 Aug 2019 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 250 in its research report dated August 12, 2019....

Hold Cadila Healthcare; target of Rs 275: Sharekhan

1.03 pm | 12 Aug 2019 |  Source: Moneycontrol.com

Sharekhan recommended Hold rating on Cadila Healthcare with a target price of Rs 275 in its research report dated August 09, 2019....

Buy Cadila Health; target of Rs 275: Motilal Oswal

1.02 pm | 12 Aug 2019 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Cadila Health has recommended buy rating on the stock with a target price of Rs 275 in its research report dated August 10...

Cadila Health Consolidated June 2019 Net Sales at Rs 3,496.30 crore, up 20.82% Y-o-Y

6.45 pm | 09 Aug 2019 |  Source: Moneycontrol.com

NULL...

Cadila Health Standalone June 2019 Net Sales at Rs 1,343.80 crore, down 10.71% Y-o-Y

6.45 pm | 09 Aug 2019 |  Source: Moneycontrol.com

NULL...

Cadila Healthcare Q1 PAT may dip 22.4% YoY to Rs. 366.7 cr: Prabhudas Lilladher

4.33 pm | 12 Jul 2019 |  Source: Moneycontrol.com

Net Sales are expected to increase by 13.9 percent Y-o-Y (down 11.7 percent Q-o-Q) to Rs. 3,296.1 crore, according to Prabhudas Lilladher....

Hold Cadila Healthcare; target of Rs 280: ICICI Direct

12.04 pm | 18 Jun 2019 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 280 in its research report dated May 30, 2019....

1
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.